PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Yearbook of Surgery10.1016/s0090-3671(08)79241-320082008327-329Effect of Infliximab on Short-Term Complications in Patients Undergoing Operation for Chronic Ulcerative ColitisM.T. Hawnhttps://api.elsevier.com/content/article/PII:S0090367108792413?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0090367108792413?httpAccept=text/plain
Yearbook of Gastroenterology10.1016/s0739-5930(08)79229-820082008240-242Effect of Infliximab on Short-Term Complications in Patients Undergoing Operation for Chronic Ulcerative ColitisJ.L. Rombeauhttps://api.elsevier.com/content/article/PII:S0739593008792298?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0739593008792298?httpAccept=text/plain
Alimentary Pharmacology & Therapeutics10.1111/j.1365-2036.2006.03131.x200625119-37Systematic review: infliximab therapy in ulcerative colitisJ. P. GISBERT, Y. GONZÁLEZ-LAMA, J. MATÉhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2036.2006.03131.x, http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2006.03131.x/fullpdf
Medical Therapy of Ulcerative Colitis10.1007/978-1-4939-1677-1_152014175-184Infliximab for Ulcerative ColitisMarc Ferrante, Séverine Vermeire, Gert Van Assche, Paul Rutgeertshttps://link.springer.com/content/pdf/10.1007/978-1-4939-1677-1_15
Crohn's Disease and Ulcerative Colitis10.1007/978-3-319-33703-6_422017429-433Biologic Therapy in Moderate-to-Severe Ulcerative Colitis: InfliximabMindy Lam, Brian Bresslerhttp://link.springer.com/content/pdf/10.1007/978-3-319-33703-6_42
Nature Reviews Gastroenterology & Hepatology10.1038/nrgastro.2012.2042012912687-687Effect of preoperative infliximab on postoperative complications in patients with ulcerative colitishttp://www.nature.com/articles/nrgastro.2012.204.pdf, http://www.nature.com/articles/nrgastro.2012.204, http://www.nature.com/articles/nrgastro.2012.204.pdf
Internal Medicine News10.1016/s1097-8690(07)71368-92007402229Ulcerative Colitis Patients Benefit From InfliximabMITCHEL L. ZOLERhttps://api.elsevier.com/content/article/PII:S1097869007713689?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1097869007713689?httpAccept=text/plain
Intestinal Research10.5217/ir.2014.12.3.2142014123214The Effect of Infliximab on Patients with Ulcerative Colitis in KoreaHyun Il Seo, Dong Il Park, Tae Oh Kim, You Sun Kim, Suck-Ho Lee, Ji Won Kim, Jae Hak Kim, Jeong Eun Shinhttp://www.irjournal.org/upload/pdf/ir-12-214.pdf
Medical Therapy of Ulcerative Colitis10.1007/978-1-4939-1677-1_162014185-190Beyond Infliximab: Other Anti-TNF Therapies for Ulcerative ColitisMing-Hsi Wang, Jean-Paul Achkarhttps://link.springer.com/content/pdf/10.1007/978-1-4939-1677-1_16
Journal of Gastroenterology and Hepatology10.1111/jgh.13008201530101467-1472Changes in cytokine profile may predict therapeutic efficacy of infliximab in patients with ulcerative colitisShoko Sato, Toshimi Chiba, Shotaro Nakamura, Takayuki Matsumotohttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjgh.13008, https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fjgh.13008, http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.13008/fullpdf